DESCRIPTION
Thymagen is a short-chain peptide bioregulator derived from the thymus peptide family. It is studied for its potential to support immune function, cellular regulation, and age-related immune decline. Research explores its role in modulating gene expression, supporting thymic activity, and enhancing immune resilience in various biological models.
BENEFITS
-
Studied for supporting immune system balance
-
Explored for improving cellular regulation and recovery
-
Interest in age-related immune decline and thymic support
-
May influence gene expression linked to immune activity
-
Investigated for anti-inflammatory and restorative pathways
WHAT RESEARCHERS LOOK AT
-
Modulation of thymic peptides and immune gene expression
-
Effects on immune cell regulation and maturation
-
Peptide-mediated improvement of recovery and resilience
-
Anti-inflammatory activity in preclinical models
-
Comparative activity vs. other thymus-derived bioregulators
QUICK SPECS
-
Form: Lyophilized peptide
-
Net per vial: 20 mg
-
Purity: ≥99% (HPLC)
-
Identity: MS-verified (per COA)
-
Storage: 2–8 °C, protect from light
IDENTITY BASICS
-
Type: Thymic bioregulatory peptide
-
Sequence: Not publicly disclosed (cytomedin class)
-
CAS: N/A (thymic peptide family)
-
Molecular Weight: Not standardized in open literature
SELECTED RESEARCH
DISCLAIMER
-
This product is intended for laboratory research use only.
-
Not for human or veterinary use.
-
Not approved for diagnostic, therapeutic, or medical applications.
-
Handle using appropriate laboratory safety procedures and personal protective equipment.
